SYNTHESIS AND ANTIVIRAL ACTIVITY OF (E)-5-(2-BROMOVINYL)URACIL AND (E)-5-(2-BROMOVINYL)URIDINE

[1] ON THE MECHANISM OF SELECTIVE-INHIBITION OF HERPESVIRUS REPLICATION BY (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (05): : 2698 - 2702

[2] ALLAUDEEN HS, 1982, J BIOL CHEM, V257, P603

[3] SYNTHESIS OF SOME 5-HALOGENOVINYL DERIVATIVES OF URACIL AND THEIR CONVERSION INTO 2'-DEOXYRIBONUCLEOSIDES [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (06): : 1665 - 1670

[4] ORAL BVDU TREATMENT OF VARICELLA AND ZOSTER IN CHILDREN WITH CANCER [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1985, 143 (03) : 198 - 202

[5] SYNTHESIS OF (E)-5-(3,3,3-TRIFLUORO-1-PROPENYL)-2'-DEOXYURIDINE AND RELATED ANALOGS - POTENT AND UNUSUALLY SELECTIVE ANTIVIRAL ACTIVITY OF (E)-5-(3,3,3-TRIFLUORO-1-PROPENYL)-2'-DEOXYURIDINE AGAINST HERPES-SIMPLEX VIRUS TYPE-1 [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) : 279 - 284

[6] BLEACKLEY RC, 1976, TETRAHEDRON, V32, P2795, DOI 10.1016/0040-4020(76)80125-1

[7] ANTI-HERPES SIMPLEX VIRUS AND ANTI-HUMAN CELL-GROWTH ACTIVITY OF E-5-PROPENYL-2'-DEOXYURIDINE AND THE CONCEPT OF SELECTIVE PROTECTION IN ANTIVIRUS CHEMOTHERAPY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) : 957 - 961

[8] CHENG YC, 1981, MOL PHARMACOL, V20, P230

[9] CHU MYW, 1984, CANCER RES, V44, P1852

[10] ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN SEVERE HERPES-ZOSTER [J]. BRITISH MEDICAL JOURNAL, 1980, 281 (6249) : 1178 - 1178

[1] ON THE MECHANISM OF SELECTIVE-INHIBITION OF HERPESVIRUS REPLICATION BY (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (05): : 2698 - 2702

[2] ALLAUDEEN HS, 1982, J BIOL CHEM, V257, P603

[3] SYNTHESIS OF SOME 5-HALOGENOVINYL DERIVATIVES OF URACIL AND THEIR CONVERSION INTO 2'-DEOXYRIBONUCLEOSIDES [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (06): : 1665 - 1670

[4] ORAL BVDU TREATMENT OF VARICELLA AND ZOSTER IN CHILDREN WITH CANCER [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1985, 143 (03) : 198 - 202

[5] SYNTHESIS OF (E)-5-(3,3,3-TRIFLUORO-1-PROPENYL)-2'-DEOXYURIDINE AND RELATED ANALOGS - POTENT AND UNUSUALLY SELECTIVE ANTIVIRAL ACTIVITY OF (E)-5-(3,3,3-TRIFLUORO-1-PROPENYL)-2'-DEOXYURIDINE AGAINST HERPES-SIMPLEX VIRUS TYPE-1 [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) : 279 - 284

[6] BLEACKLEY RC, 1976, TETRAHEDRON, V32, P2795, DOI 10.1016/0040-4020(76)80125-1

[7] ANTI-HERPES SIMPLEX VIRUS AND ANTI-HUMAN CELL-GROWTH ACTIVITY OF E-5-PROPENYL-2'-DEOXYURIDINE AND THE CONCEPT OF SELECTIVE PROTECTION IN ANTIVIRUS CHEMOTHERAPY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) : 957 - 961

[8] CHENG YC, 1981, MOL PHARMACOL, V20, P230

[9] CHU MYW, 1984, CANCER RES, V44, P1852

[10] ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN SEVERE HERPES-ZOSTER [J]. BRITISH MEDICAL JOURNAL, 1980, 281 (6249) : 1178 - 1178